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Compared efficacy and safety of a standard versus a loading dose of
clopidogrel at the acute stage of myocardial infarction in elderly
patients. The FAST-MI registry data.
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Background: 
 
Data are lacking on the efficacy and safety of a loading dose
of clopidogrel in the elderly
 
 
 
with acute myocardial infraction (AMI).
 
Aim:
 
 To determine 30-day and one-year mortality, as well as in-hospital
bleeding risk in elderly patients with AMI according to the use of a loading
dose of clopidogrel (
 
≥
 
 300 mg).
 
Methods: 
 
FAST-MI is a nationwide registry carried out over a 1-month
period in 2005, including consecutive patients with AMI admitted to ICUs <
48 hours from symptom onset in 223 participating centers. We assessed impact
of clopidogrel loading dose on bleeding, the need for blood transfusion and
12-month survival in elderly patients (aged 
 
≥
 
 75 years). 
 
Results: 
 
791 elderly patients were included (Mean age 81 ± 4 years, 48 %
women; 35% STEMI). 59% (466 patients) have received a clopidogrel loading
dose (
 
≥
 
 300mg).
 
 
 
Follow up was > 98% complete. Major bleeding and blood
transfusions were not significantly different in patients having received a
loading dose of clopidogrel or a conventional 75 mg dose, respectively 3.7 vs.
3.2 (p>0,05) and 6.2 vs. 5.4 (p>0,05). Early and one-year mortality were also
not significantly different. Using multivariate analyses: Clopidogrel loading
dose was not associated with a significant increase major bleeding or transfu-
sion (OR=1.09; 95%CI:0.50-2.40, p=0.82); and 12-month mortality (OR=0.95;
95%CI:0.65-1.29, p=0.61).
 
Conclusion: 
 
The present data show that in elderly patients admitted for AMI,
use of a loading dose of clopidogrel was not associated with increased in-hospital
bleeding, need for transfusion, or mortality. These results persisted after muti-
variate adjustment. Large-scale randomized trials are still needed to identify the
optimal loading dose of clopidogrel for elderly patients admitted for AMI.
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ST-elevation myocardial infarction admission during "ON-" versus
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Background: 
 
It has been suggested that delays, quality and outcome of
reperfusion therapy provided to ST-Elevation Myocardial Infarction (STEMI)
patients during OFF-hours (nights and weekend) are worse than during ON-
hours (day working hours).
 
Methods: 
 
We studied 736 consecutive STEMI patients transferred for pri-
mary percutaneous intervention (PCI) to a single large volume urban Primary
PCI center. Characteristics and clinical outcome of patients admitted during
ON-hours (Monday through Friday 8 am-6 pm) were compared to OFF-hours
patients (admitted during night shifts and weekends). Clinical outcome was 1
year death and death or MI. 
 
Results: 
 
STEMI patients undergoing primary PCI were admitted more fre-
quently during OFF-hours (n=449; 61.1%) than ON-hours (n=287; 38.9%), with
no major differences in characteristics or treatment between the two groups. Use
of radial approach and the rate of stenting during PCI was 83.3% and 86.1% in
ON-hours patients vs. 88.2%.and 88.1% in OFF-hours patients. There was no
impact of time of admission on in-hospital mortality before or after adjustment for
baseline characteristics OR 1.54; CI [0.71-3.35]. Time from symptom onset to first
medical contact was shorter during OFF-hours than ON-hours (105 min [50-225]
vs. 114 min [60-367]; p=0.06). Time from first medical contact to sheath insertion
was also identical between the 2 groups (101 min [80-155] and 105 min [78-155];
p=0.61 respectively). Time to TIMI 3 flow and duration of procedure were also
similar. At one year, all cause mortality and the composite end point of death or
MI was 8.3% and 12.2% for OFF-hours patients vs. 7.0% and 10,8% in ON-hours
patients, p=0.4 and p=0.3 respectively. 
 
 
Conclusion: 
 
In a well-organized urban STEMI network, were 61% of patients
referred for primary PCI are admitted during “OFF” hours, admission time does
not impact quality of care or outcomes.
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After urgent percutaneous coronary intervention (PCI) in ST elevation
myocardial infarction (STEMI), a sizable proportion of patients achieve epi-
cardial but not myocardial reperfusion. This condition known as no reflow
phenomenon is associated with a worse prognosis. 
 
Aim:
 
 to determine the incidence and clinical and angiographic risk factors of
No reflow. Population, methods and results: Our cohort included 900 consecu-
tive patients with STEMI (mean age 59.2+/- 13.3 years, 87.7% males) referred
to our service for primary or rescue PCI. Patients presented with anterior myo-
cardial infarction in 62.2% of cases, cardiovascular risk factors were: smoking:
87.7%, diabetes:31.1%, hypertension: 37.7% and dyslipidemia: 20%. Patients
had an intinial TIMI flow = 0 before the procedure in 90.1% of cases and they
achieve a TIMI 3 flow after PCI in 65.5% of cases. No reflow phenomenon
occured in 24.4% of patients and were associated to poorer in hospital prognosis
with more frequent major cardiovascular events (cardiac insufficiency, choc, re-
infarction and death) (17.6% vs 6.1%, p<0.01). Identified independant predictor
factors of no reflow phenomenon were final TIMI flow inferior to 3 (68.2 vs
22.1% p<0.01, RR=3.6), presence of multiple thrombus fragments or thrombus
in front of the culpurite lesion (65.1% vs 31%, p<0.01, RR=2.9) and longer
delay to intervention (11.5+/-6.1 vs 7.7+/-5.7 hours, RR=1.8). Thromboaspira-
tion was the only therapeutic measure reducing the risk of no reflow phenom-
enon in this cohort (16.3% vs 35.8%, p<0.01).
Death or MI after one year of follow-up
 © Elsevier Masson SAS. All rights reserved.
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Conclusion:
 
 Thromboaspiration should be proposed systematically in case
of STEMI to reduce the risk of no reflow particularly in the presence of clin-
ical or angiographic predictive factors of this phenomenon.
 
007
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Background: 
 
Recent data suggest that fractional flow reserve (FFR) is
useful in guiding coronary revascularization. There is however currently no
large report of the use of this technology in France, in particular its impact on
the decision of coronary revascularization.
 
Methods: 
 
The R3F registry investigated the use of FFR in 20 French cen-
ters from October 2008 to June 2010. To investigate this issue the investiga-
tors defined prospectively their revascularization strategy "a priori" before
performing the FFR. This was compared to the final strategy applied to the
patient after performing the FFR. The results of the first 945 consecutive
patients are presented.
 
Results:
 
 75% of patients were males with a mean age of 65±10 years, 37%
were diabetics and 19% had a recent ACS. Patients had non-significant (<
50% stenosis) angiographic coronary artery disease (14%), significant (>50%)
angiographic 1-vessel (37%), 2-vessel (30%) or 3-vessel disease (19%). The
strategy defined “a-priori” by the investigators was medical therapy (52%),
PCI (37%), and CABG (11%). After the results of FFR the final strategy was
medical therapy in 58% and coronary revascularization in 42% (PCI in 31%
and CABG in 11%). Interestingly in 45% of cases the strategy defined “a
priori” was modified by the results of the FFR: 
1) In 36% of the patients in which a medical therapy was planed “a priori” the
strategy was modified for PCI (26%) or CABG (10%); 
2) In 58% of the patients in which a PCI was considered “a priori” the strategy
was modified for medical therapy (50%) or CABG (8%); 
3) In 68% of the patients in which a CABG was considered “a priori” the
strategy was modified for medical therapy (64%) or PCI (4%).
 
Conclusion:
 
 The present report, based on a large French multicenter reg-
istry, demonstrated that although FFR had little impact on the overall rate of
revascularization, it modified the individual decision in almost 1 out of 2
patients.
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Non invasive coronary flow reserve is a powerful independent predic-
tor of in-hospital complications in Tako-Tsubo syndrome
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Several in-hospital complications (HC) could impair the clinical course of
tako-tsubo syndrome (TTS). 
 
Objective:
 
 to assess the clinical and echocardiographic predictors of HC in
TTS. 
 
Methods:
 
 37 consecutive patients (pts) (mean age, 69 ± 10 years, 35
women) with a typical TTS according to the Mayo Clinic criteria underwent
prospectively a comprehensive transthoracic Doppler-echocardiography
including the non invasive assessment of coronary flow reserve (CFR), mea-
sured in the distal part of the left anterior descending artery using intravenous
adenosine infusion, at the acute phase (within 24-48 h of symptom onset) and
after recovery (1 month apart). Clinical and biochemical parameters were also
assessed. HC were defined as cardiogenic shock, or thrombo-embolic event. 
 
Results:
 
 HC occurred in 8 cases (22%). Pts with HC, compared to pts
without HC, were more frequently diabetics (63% vs. 21%, p < 0.05), and had
at the acute phase a more severely impaired CFR (1.8 ± 0.5 vs. 2.3 ± 0.4,
p<0.01), left ventricular (LV) ejection fraction (33 ± 8 % vs. 41 ± 9 %,), wall
motion score index, and LV systolic volume/m
 
2
 
 (all, p < 0.05), Age, frequency
of ECG ST-segment elevation at presentation, troponin peak, and preexisting
beta-blockers use, were not significantly different in pts with and without HC
(all, p = NS). The in-hospital length of stay was longer in the former group (
p < 0.05). After recovery, CFR improved significantly in both groups. How-
ever, the magnitude of improvement was higher in pts with HC as compared
to pts without HC (74 % vs. 27 %, p < 0.05) leading to final value of CFR
similar in both groups (2.9 ± 0.4 vs. 3.1 ± 0.6, p = NS). In multivariate anal-
ysis, the only independent predictor of HC was acute CFR (p = 0.028). Using
a ROC curve analysis a CFR < 1.9 was the best cut-off to predict HC with a
sensitivity of 75% and specificity of 86%, (AUC 0.76, p < 0.01). With a mean
follow-up of 24 ± 10 months, one patient died in the group of HC vs. none in
the other group.
 
Conclusion:
 
 CFR is an independent predictor of HC, suggesting that the
impairment of the coronary microcirculation is important at the acute phase of
TTS. 
 
 009
 
Impact of early vs late microvascular obstruction on ventricular
remodeling at 6 months assessed by 3-Tesla magnetic resonance ima-
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Background:
 
 Microvascular obstruction (MVO) at the acute phase of
myocardial infarction (MI) is associated with greater myocardial damage, left
ventricular (LV) impairment and higher mortality. We compared the impact of
early and late microvascular obstruction (MVO) as assessed by 3-T cardiac
magnetic resonance imaging (MRI) at the acute phase of MI on LV remod-
eling at 6 months.
 
Methods:
 
 We included 51 consecutive patients (pts) with no previous his-
tory of cardiovascular disease, and presenting for first MI with or without ST
elevation. Infarct size and extent of no-reflow were evaluated by 3-T MRI
during acute phase by early and late hyperenhancement imaging at 3 and 15
min after gadolinium injection. Extent of no-reflow at 3 minutes (early MVO)
and 15 minutes (late MVO) was measured. Follow-up MRI was performed at
6 months. Systolic and diastolic LV volumes, as well as LV ejection fraction
and infarct size were compared at baseline and 6 months.
 
Results:
 
 Incidence of early MVO was 56% vs 43% for late MVO. There
was a significant difference in extent of no-reflow between early and late
MVO (7.8±4% vs 5.4±4%, p<0.0001, early vs late respectively). There was
also a significant difference in LV evolution at 6 months between pts with and
without no-reflow (p<0.05). In pts who showed no-reflow at 3 minutes only,
but not at 15 minutes, ventricular dilatation was observed at 6 month follow-
up of a magnitude similar to that observed in pts with persistent no-reflow at
15 minutes.
 
Conclusion:
 
 Incidence of MVO is higher when assessed at 3 minutes,
rather than at 15 minutes. In this context, systematic early MVO evaluation
could help identify a larger group of pts at risk of unfavourable evolution,
because when MVO is evaluated at 15 minutes, pts who had no-reflow at 3
minutes that subsequently resolved, go unidentified. The presence of MVO is
associated with LV dilatation at 6 months follow-up, regardless of whether no-
reflow was present at 3 minutes only, or persistent at 15 minutes.
